FDA.reportPublic FDA data

Alvaiz 18 MG Oral Tablet

RxCUI
2675193
RxNorm name
Alvaiz 18 MG Oral Tablet
Display name
Alvaiz 18 MG Oral Tablet
Full name
Alvaiz 18 MG Oral Tablet
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:26

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ALVAIZELTROMBOPAGTeva Pharmaceuticals, Inc.ed51e463-7a03-4858-bbd2-882ce4753d5a2026-01-30Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2675193

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
ed51e463-7a03-4858-bbd2-882ce4753d5aAlvaiz 18 MG Oral TabletPSN7These highlights do not include all the information needed to use ALVAIZ safely and effectively. See full prescribing information for ALVAIZ . ALVAIZ ® (eltrombopag tablets), for oral use Initial U.S. Approval: 200820260130
ed51e463-7a03-4858-bbd2-882ce4753d5aAlvaiz 18 MG Oral TabletSY7These highlights do not include all the information needed to use ALVAIZ safely and effectively. See full prescribing information for ALVAIZ . ALVAIZ ® (eltrombopag tablets), for oral use Initial U.S. Approval: 200820260130
ed51e463-7a03-4858-bbd2-882ce4753d5aeltrombopag 18 MG Oral Tablet [Alvaiz]SBD7These highlights do not include all the information needed to use ALVAIZ safely and effectively. See full prescribing information for ALVAIZ . ALVAIZ ® (eltrombopag tablets), for oral use Initial U.S. Approval: 200820260130
ed51e463-7a03-4858-bbd2-882ce4753d5aAlvaiz 18 MG (as eltrombopag choline 22.2 MG) Oral TabletSY7These highlights do not include all the information needed to use ALVAIZ safely and effectively. See full prescribing information for ALVAIZ . ALVAIZ ® (eltrombopag tablets), for oral use Initial U.S. Approval: 200820260130